Table 3.
Univariate analysis of poor prognosis in patients with coronary heart disease.
| Factors | MACE group | Non-MACE group | t/χ2 | p |
|---|---|---|---|---|
| n = 40 | n = 57 | |||
| Gender (n (%)) | 0.053 | 0.818 | ||
| Male | 22 (55.00) | 30 (52.63) | ||
| Female | 18 (45.00) | 27 (47.37) | ||
| Age/years old | 52.26 ± 6.35 | 52.44 ± 6.51 | 0.135 | 0.893 |
| BMI (kg/m2) | 23.49 ± 2.22 | 23.58 ± 2.18 | 0.199 | 0.843 |
| Lesion vessels | 7.406 | 0.025 | ||
| Single vessel | 10 (25.00) | 21 (36.84) | ||
| Double vessel | 11 (27.50) | 26 (45.61) | ||
| Multiple vessels | 19 (47.50) | 13 (22.81) | ||
| FAF | 0.43 ± 0.09 | 0.71 ± 0.13 | 11.78 | <0.001 |
| HCY (μmol/L) | 26.31 ± 4.26 | 20.09 ± 3.81 | 7.537 | <0.001 |
| Lp-a (mmol/L) | 228.45 ± 18.31 | 202.66 ± 15.73 | 7.426 | <0.001 |
| TNF-α (pg/mL) | 67.26 ± 7.02 | 66.05 ± 7.11 | 0.829 | 0.409 |
| hsCRP (mg/L) | 9.63 ± 1.02 | 7.83 ± 1.06 | 8.361 | <0.001 |